Ripple Science Makes Waves to Transform Patient Recruitment
Ripple Science Selected to Present at the 2019 Midwest Growth Capital Symposium
ANN ARBOR, Michigan – May 16, 2019– Ripple Science is working to solve the problems associated with finding and retaining patients in clinical research studies.
Created by Dr. Nestor Lopez-Duran at the University of Michigan to improve the recruitment and management of research participants, Ripple software is used to coordinate all aspects of patient management as a consolidated solution replacing existing tools that were simply not robust enough for the needs of researchers.
“We launched Ripple in December 2016 with an initial goal of improving participant recruitment and providing a simple participant management tool for researchers,” says Dr. Lopez-Duran, Ripple Science founder. “Today, we have more than 650 active Ripple users around the world. We have grown and transformed patient workflow in clinical, translational and social science studies faster than we could have ever imagined.”
Peter Falzon, Ripple Science CEO and President, presented to investors at the 2019 Midwest Growth Capital Symposium, announcing the company’s plans to launch a new product to support biopharma sponsored research teams and expanding the company’s reach beyond the academic research market it currently serves.
To date, Ripple Science has raised $1.8 million in seed round investment from venture funds and angels.
Falzon’s presentation to investors at MGCS is in anticipation of raising a Series A round later this year. The funding will enable Ripple Science to ramp its marketing and sales operations.
About Ripple Science
Ripple Science accelerates clinical research with its secure, HIPAA-compliant suite of tools. By adapting sales and marketing automation to the process of patient recruitment, Ripple helps our customers recruit more participants, faster and reduces patients lost to follow-up.
Ripple Science’s flagship product, Ripple, is currently being used by research investigators at more than 50 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.